As of 2:30 PM on the 7th, Komipharm is trading at 13,150 KRW, up 0.38% from the previous day. This is a 4.01% decrease compared to November 20. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.

Today, foreigners are tentatively recorded as net buyers of 29,854 shares. Over the past five days, individual investors have been net buyers of 216,260 shares, while foreigners and institutions have been net sellers of 129,151 shares and 91,556 shares, respectively.


On December 4, Komipharm was a market topic for its "strength following Phase 2 clinical trial approval."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing